COVID-19 advice hub

COVID-19 advice hub

Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). As of 11 March 2020, the rapid circulation of SARS-CoV-2 has been classified as a pandemic by the World Health Organization.

This page is collates relevant guidance from NHS England, Public Health England, the UK Government, and professional bodies across the UK and beyond to support services with both the design and delivery of their pandemic response.

Jump to the following areas based on your needs:

Prevention

Investigation

Service organisation and resourcing

    1. stepping back up of key reporting and management functions
    2. freeing up maximum possible inpatient and critical care capacity
    3. preparing, and responding to, large numbers of inpatients requiring respiratory support
    4. supporting staff, and maximising staff availability
    5. supporting newly announced wider population measures
    6. stress-testing operational readiness
    7. removing routine burdens
    1. Phase 1: COVID-19 case identification and immediate response
    2. Phase 2: COVID-19 coordination services
    3. Minimum pathway accessories required, including for diagnostics, case transport, and infection prevention and control
    4. Managing illness during self-isolation based on symptom severity (‘disposition’).

NHS England


Royal College of Anaesthetists, Association of Anaesthetists, Faculty of Intensive Care Medicine, Intensive Care Society, and UK Clinical Pharmacy Association


Clinical management of acute COVID-19-related illness

Acute care

COVID-19 rapid NICE guidelines:

Rapid evidence summaries:

National Institute for Health and Care Excellence


Specific treatments:



Faculty of Intensive Care Medicine




Specific patient groups and conditions

Adrenal/pituitary insufficiency


Asthma


Cancer

Chronic myeloid leukaemia

Liver cancer


Cardiovascular disease


Chronic obstructive pulmonary disease


Coagulopathy


Congenital heart disease


Diabetes


Fragility fractures


Gastroenterology


Gynaecology


Haematology


Hepatology


HIV


Hypertension

Receiving angiotensin-converting enzyme inhibitor (ACEi) or angiotensin receptor blocker (ARB) therapy

The current international consensus is that there is no good evidence that stopping ACEis or ARBs will prevent or alleviate COVID-19.


Immune thrombocytopenic purpura


Immunosuppression


Inflammatory bowel disease (including Crohn’s disease and ulcerative colitis)


Interstitial lung disease


Lung cancer and mesothelioma


Multiple sclerosis


Obstructive sleep apnoea


Ophthalmology


Paediatrics


Psoriasis


Pregnancy


Rheumatological conditions


Sickle cell disease and thalassaemia


Stroke


Surgery


Transfusion


Transplantation


Trauma and orthopaedics


Patients taking warfarin


Equipment standards


Pharmacy

Other areas

Advising the public

Specialised Medicine COVID-19 news

The latest news on COVID-19

New report: maintaining a cancer service in the midst of the COVID-19 pandemic

A third of patients with cancer report disruptions to their treatment caused by the pandemic

Research study examining ‘long COVID’ launched in the UK

Public Health England issues updated infection prevention and control guidance

NICE updates a series of COVID-19 rapid guidelines

Report on the health and social care response to COVID-19 published

Letter on third phase of NHS response to COVID-19 released

NHS announces £160 million funding for COVID-friendly cancer treatments

New study examines the effect of COVID-19 on the cardiovascular system

PHE publishes new evidence on the relationship between excess weight and COVID-19

NICE publishes COVID-19 guidance on arranging planned care in hospitals and diagnostic services

The Nuffield Trust issues guide to resuming health services during the COVID-19 pandemic

Priorities for health and care following the COVID-19 pandemic identified by The King’s Fund

Position paper on mental healthcare reform after COVID-19 published

New study examines the impact of COVID-19 on cancer deaths in England

Tool created to monitor the wider impacts of COVID-19 on health

Interferon beta treatment may reduce the need for intensive care in patients with COVID-19

PHE issues guidance on maintaining immunisation programmes during the COVID-19 pandemic

Neurological associations of COVID-19 reported

Shielding to end for the majority of clinical extremely vulnerable children

Royal Osteoporosis Society publishes guidance on care during and beyond the pandemic

Risk of ischaemic stroke higher with COVID-19 than influenza

Interim clinical commissioning policy on remdesivir published by the MHRA

New guide providing practical support to stroke services during the COVID-19 pandemic published

NICE publishes rapid evidence summary on vitamin D for COVID-19

The impact of cancer on young people during the COVID-19 pandemic

For more stories, visit the Specialised Medicine news archive.